Text

Text

Risperdal
July 24, 2012 – Johnson & Johnson, the company that makes the antipsychotic drug Risperdal, has tentatively agreed to a settlement of $2.2 billion to resolve a federal investigation into the company’s marketing practices. Although details are not fully finalized, this includes “a roughly $400 million criminal fine for the illegal promotion of the antipsychotic Risperdal,” according to the Wall Street Journal. Click Here to read the rest of this article.

Paxil
Another pharmaceutical company, GlaxoSmithKline, faces $3 billion in penalties after pleading guilty to the biggest health
care fraud case in history. GSK admitted that physicians had been bribed to push potentially dangerous drugs in exchange for Madonna tickets, Hawaiian holidays, cash and lucrative speaking tours. They also admitted distributing misleading information regarding the antidepressant Paxil. The report claimed that it was suitable for children, but failed to acknowledge data from studies proving its ineffectiveness in children and adolescents.
Click Here to read the rest of this article.